Literature DB >> 28510030

Tri-modal regulation of cardiac muscle relaxation; intracellular calcium decline, thin filament deactivation, and cross-bridge cycling kinetics.

Brandon J Biesiadecki1, Jonathan P Davis1, Mark T Ziolo1, Paul M L Janssen2.   

Abstract

Cardiac muscle relaxation is an essential step in the cardiac cycle. Even when the contraction of the heart is normal and forceful, a relaxation phase that is too slow will limit proper filling of the ventricles. Relaxation is too often thought of as a mere passive process that follows contraction. However, many decades of advancements in our understanding of cardiac muscle relaxation have shown it is a highly complex and well-regulated process. In this review, we will discuss three distinct events that can limit the rate of cardiac muscle relaxation: the rate of intracellular calcium decline, the rate of thin-filament de-activation, and the rate of cross-bridge cycling. Each of these processes are directly impacted by a plethora of molecular events. In addition, these three processes interact with each other, further complicating our understanding of relaxation. Each of these processes is continuously modulated by the need to couple bodily oxygen demand to cardiac output by the major cardiac physiological regulators. Length-dependent activation, frequency-dependent activation, and beta-adrenergic regulation all directly and indirectly modulate calcium decline, thin-filament deactivation, and cross-bridge kinetics. We hope to convey our conclusion that cardiac muscle relaxation is a process of intricate checks and balances, and should not be thought of as a single rate-limiting step that is regulated at a single protein level. Cardiac muscle relaxation is a system level property that requires fundamental integration of three governing systems: intracellular calcium decline, thin filament deactivation, and cross-bridge cycling kinetics.

Entities:  

Keywords:  Calcium handling; Cardiac relaxation; Contraction; Diastole; Kinetics; Myofilaments

Year:  2014        PMID: 28510030      PMCID: PMC4255972          DOI: 10.1007/s12551-014-0143-5

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  26 in total

1.  Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.

Authors:  Ying H Lin; William Schmidt; Kristofer S Fritz; Mark Y Jeong; Anthony Cammarato; D Brian Foster; Brandon J Biesiadecki; Timothy A McKinsey; Kathleen C Woulfe
Journal:  J Mol Cell Cardiol       Date:  2020-01-22       Impact factor: 5.000

Review 2.  Designing proteins to combat disease: Cardiac troponin C as an example.

Authors:  Jonathan P Davis; Vikram Shettigar; Svetlana B Tikunova; Sean C Little; Bin Liu; Jalal K Siddiqui; Paul M L Janssen; Mark T Ziolo; Shane D Walton
Journal:  Arch Biochem Biophys       Date:  2016-02-18       Impact factor: 4.013

3.  The lack of slow force response in failing rat myocardium: role of stretch-induced modulation of Ca-TnC kinetics.

Authors:  Oleg Lookin; Yuri Protsenko
Journal:  J Physiol Sci       Date:  2018-12-18       Impact factor: 2.781

4.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

5.  Jack-of-many-trades: discovering new roles for troponin C.

Authors:  Kerry S McDonald
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

6.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

7.  Successful Identification of Cardiac Troponin Calcium Sensitizers Using a Combination of Virtual Screening and ROC Analysis of Known Troponin C Binders.

Authors:  Melanie L Aprahamian; Svetlana B Tikunova; Morgan V Price; Andres F Cuesta; Jonathan P Davis; Steffen Lindert
Journal:  J Chem Inf Model       Date:  2017-11-16       Impact factor: 4.956

8.  Etiology-dependent impairment of relaxation kinetics in right ventricular end-stage failing human myocardium.

Authors:  Jae-Hoon Chung; Brit L Martin; Benjamin D Canan; Mohammad T Elnakish; Nima Milani-Nejad; Nancy S Saad; Steven J Repas; J Eric J Schultz; Jason D Murray; Jessica L Slabaugh; Rachel L Gearinger; Jennifer Conkle; Tallib Karaze; Neha Rastogi; Mei-Pian Chen; Will Crecelius; Kyra K Peczkowski; Mark T Ziolo; Vadim V Fedorov; Ahmet Kilic; Bryan A Whitson; Robert S D Higgins; Sakima A Smith; Peter J Mohler; Philip F Binkley; Paul M L Janssen
Journal:  J Mol Cell Cardiol       Date:  2018-07-05       Impact factor: 5.000

9.  Mouse embryonic stem cell-derived cardiomyocytes cease to beat following exposure to monochromatic light: association with increased ROS and loss of calcium transients.

Authors:  Gurbind Singh; Divya Sridharan; Mahmood Khan; Polani B Seshagiri
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-17       Impact factor: 4.249

Review 10.  Myocardial relaxation in human heart failure: Why sarcomere kinetics should be center-stage.

Authors:  Paul M L Janssen
Journal:  Arch Biochem Biophys       Date:  2018-11-14       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.